Gilead to widen testing of drug to treat coronavirus in Hong Kong, other Asian markets

Biopharmaceutical firm Gilead will pursue new clinical studies for its experimental drug remdesivir in Hong Kong, South Korea, Taiwan and Singapore, as well as other countries with high numbers of diagnosed coronavirus cases.